{"id":"https://openalex.org/W2539905046","doi":"https://doi.org/10.1016/j.jval.2016.09.2234","title":"Cost-Effectiveness of Ibrutinib in Adult Patients with Relapsed Chronic Lymphocytic Leukaemia in the Netherlands","display_name":"Cost-Effectiveness of Ibrutinib in Adult Patients with Relapsed Chronic Lymphocytic Leukaemia in the Netherlands","publication_year":2016,"publication_date":"2016-10-31","ids":{"openalex":"https://openalex.org/W2539905046","doi":"https://doi.org/10.1016/j.jval.2016.09.2234","mag":"2539905046"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2016.09.2234","doi":"https://doi.org/10.1016/j.jval.2016.09.2234","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2016.09.2234","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301516336002/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.valueinhealthjournal.com/article/S1098301516336002/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025862058","display_name":"H Welten","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Welten","raw_affiliation_strings":["Janssen-Cilag BV, Tilburg, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen-Cilag BV, Tilburg, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067941899","display_name":"TJ Ignacio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094451","display_name":"Pharmerit (Netherlands)","ror":"https://ror.org/00ntr9f13","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210094451","https://openalex.org/I4210134090"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"TJ Ignacio","raw_affiliation_strings":["Pharmerit International, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmerit International, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4210094451"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109223880","display_name":"Bram G. Verheggen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094451","display_name":"Pharmerit (Netherlands)","ror":"https://ror.org/00ntr9f13","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210094451","https://openalex.org/I4210134090"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"BG Verheggen","raw_affiliation_strings":["Pharmerit International, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmerit International, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4210094451"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":0.4606,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.63870482,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"19","issue":"7","first_page":"A737","last_page":"A737"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.02969999983906746,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":1.0},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9890000224113464},{"id":"https://openalex.org/keywords/health-benefits","display_name":"health benefits","score":0.8429999947547913},{"id":"https://openalex.org/keywords/societal-perspective","display_name":"societal perspective","score":0.7829999923706055}],"concepts":[{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.9400739073753357},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.9199358820915222},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8258345127105713},{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.7481257319450378},{"id":"https://openalex.org/C2777866208","wikidata":"https://www.wikidata.org/wiki/Q415939","display_name":"Chlorambucil","level":4,"score":0.613301694393158},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6083939075469971},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.5818236470222473},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5298497676849365},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48817354440689087},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.4600399136543274},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4194723963737488},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.18548467755317688},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.18046122789382935},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.15924355387687683},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.14529848098754883}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2016.09.2234","doi":"https://doi.org/10.1016/j.jval.2016.09.2234","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2016.09.2234","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301516336002/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2016.09.2234","doi":"https://doi.org/10.1016/j.jval.2016.09.2234","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2016.09.2234","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301516336002/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2539905046.pdf","grobid_xml":"https://content.openalex.org/works/W2539905046.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2810015703","https://openalex.org/W2598550387","https://openalex.org/W2765594360","https://openalex.org/W2774179518","https://openalex.org/W2892153379","https://openalex.org/W2777747661","https://openalex.org/W2581607653","https://openalex.org/W3170156123","https://openalex.org/W3167947774","https://openalex.org/W3033943641"],"abstract_inverted_index":null,"counts_by_year":[{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-11-04T00:00:00"}